Litcius/Paper detail

Different mechanisms of drug resistance to hypomethylating agents in the treatment of myelodysplastic syndromes and acute myeloid leukemia

Kristína Šimoničová, Ľuboš Janotka, Helena Kavcová, Zdena Sulová, Albert Breier, Lucia Messingerová

2022Drug Resistance Updates47 citationsDOI

Topics & Concepts

Myelodysplastic syndromesAzacitidineMyeloid leukemiaDrug resistanceHypomethylating agentPharmacologyDeoxycytidine kinaseMedicineDecitabineCytidineMechanism (biology)DrugLeukemiaCancer researchBiologyDeoxycytidineImmunologyInternal medicineCancerDNA methylationBone marrowGeneticsGeneBiochemistryEpistemologyEnzymeGene expressionGemcitabinePhilosophyAcute Myeloid Leukemia ResearchPneumocystis jirovecii pneumonia detection and treatmentHIV/AIDS drug development and treatment
Different mechanisms of drug resistance to hypomethylating agents in the treatment of myelodysplastic syndromes and acute myeloid leukemia | Litcius